Guide for Real-World Evidence
Real-world data (RWD) from electronic medical records, insurance claims, and disease registries have expanded what Biotechs can learn about patient outcomes. Turned into real-world evidence (RWE), this is fast becoming a go-to tool for Biotech companies to optimize asset valuation, inform strategy and support regulator and payer decisions.
Parexel Biotech has created this guide to simplify the nomenclature and types of real-world studies.
Related Insights
Blog
Bolster your investor narrative with RWE
Jan 26, 2026
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Blog
Evidence planning for biotechs: Closing gaps to maximize value
Nov 4, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023
Related Insights
Blog
Bolster your investor narrative with RWE
Jan 26, 2026
Blog
Incorporating the patient voice in clinical research: Validation of COAs for a rare disease NDA
Nov 17, 2025
Blog
Evidence planning for biotechs: Closing gaps to maximize value
Nov 4, 2025
Webinar
Assessing appropriate use of ECAs in clinical trials
May 28, 2023
Webinar
Adaptive strategies for more efficient, data-rich and patient-friendly trials
May 28, 2023
Article
Getting to ‘No’ fast is more important when you are small
Mar 4, 2022
Article
Near-term strategies for biotech drug developers facing shifting healthcare dynamics
Feb 14, 2024
Playbook
What emerging trends in the FDA’s most coveted designations might tell us
Feb 8, 2024
Blog
Removing barriers through pragmatic clinical trials
Oct 12, 2023
Blog
A hybrid model supports globally diverse site participation for a retrospective cancer study
Jul 24, 2023
Video
The science and practice of ethnobridging
May 17, 2023
Playbook
Insights from the 2022 R&D Innovation Survey
Feb 17, 2023